19-15192188-G-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM1BP4BS2
The NM_000435.3(NOTCH3):c.451C>G(p.Gln151Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000026 in 1,460,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000435.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000450 AC: 11AN: 244384Hom.: 0 AF XY: 0.0000449 AC XY: 6AN XY: 133484
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460162Hom.: 0 Cov.: 40 AF XY: 0.0000289 AC XY: 21AN XY: 726400
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:5
This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 151 of the NOTCH3 protein (p.Gln151Glu). This variant is present in population databases (rs371491165, gnomAD 0.01%). This missense change has been observed in individuals with cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (PMID: 19006080, 19542611, 36401683). This variant is also known as c.529C>G. ClinVar contains an entry for this variant (Variation ID: 101050). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt NOTCH3 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
- -
The Q151E variant in the NOTCH3 gene has been reported previously in the heterozygous state in an individual with CADASIL, however familial segregation information was not included. (Ampuero et al., 2009). The Q151E variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Q151E variant is a semi-conservative amino acid substitution, which occurs at a position that is well-conserved across species, however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on review of the data in the context of the 2015 ACMG standards and guidelines for the interpretation of sequence variants (Richards et al., 2015), we now interpret Q151E as a variant of uncertain significance. -
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Pathogenic:1
PMID:19542611 shows that this variant was identified in one patient with CADISIL. The affected amino acid is near cysteine residues in EGF repeats which may be important for protein conformation. -
Lateral meningocele syndrome;C3809084:Myofibromatosis, infantile, 2;C4551768:Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Uncertain:1
- -
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at